Clinical Regulatory Inspections – and why I love them

Webinar – How Smart Biotechs Scale Organizations Fast and Maximize Value

According to a study from Deloitte, it is estimated that bringing a new drug to market can cost almost $2 billion (as of 2018). While the costs to develop assets are rising, the value per asset continues to decline with pricing pressures coming from every direction and increased competition in the market from expiring patents…

Copyright © 2021 YourEncore. All rights reserved. Trust Center.